A new advancement in stem cell differentiation has been developed by UNSW Australia researchers. The technique utilizes autologous stem cells treated with a series of growth factors to promote cell plasticity. The mixture is then inserted into damaged tissues, promoting growth and healing.
The stem cells were treated with 5-Azacytidine (AZA) and platelet-derived growth factor-AB (PDGF-AB) for approximately two days. The stem cells are then treated with the growth factor alone for a further two-three weeks. These two components appeared to facilitate the plasticity of the cells.
"The therapy has enormous potential for treating back and neck pain, spinal disc injury, joint and muscle degeneration and could also speed up recovery following complex surgeries where bones and joints need to integrate with the body," Dr Mobbs said, "This represents a potential huge leap forward for spinal and orthopaedic procedures."
As regenerative engineering progresses, we believe the best stem cells to use in emerging treatments will be the patient’s own [autologous stem cells] as this negates the need to find a suitable donor and eliminates the chances of rejection of the transplanted tissue. To learn more about banking your own valuable stem cells to insure your family’s future health, visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.